| Adam Craig Lustig, MD | |
|
600 Gresham Dr, Norfolk, VA 23507-1904 | |
| (757) 466-0089 | |
| Not Available |
| Full Name | Adam Craig Lustig |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 13 Years |
| Location | 600 Gresham Dr, Norfolk, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962794982 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 0101252627 (Virginia) | Secondary |
| 2085R0204X | Radiology - Vascular & Interventional Radiology | 0101252627 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sentara Norfolk General Hospital | Norfolk, VA | Hospital |
| Sentara Leigh Hospital | Norfolk, VA | Hospital |
| Sentara Williamsburg Regional Medical Center | Williamsburg, VA | Hospital |
| Sentara Careplex Hospital | Hampton, VA | Hospital |
| Sentara Virginia Beach General Hospital | Virginia beach, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medical Center Radiologists Inc | 5395640650 | 106 |
News Archive
Fate Therapeutics, Inc. announced today that the Company was named as one of Technology Review's 2010 TR50, the publication's first annual list of the 50 most innovative companies in the world. The 2010 TR50 companies span the fields of energy, computing, the Web, biomedicine, and materials and have been evaluated based on business model, strategies for deploying and scaling up its technologies and the likelihood of success. Each company in the 2010 TR50 has excelled not only at inventing technology but also at using it to transform how we live and work.
A new generation of cancer treatments based on nanotechnology is making its way out of the laboratory and into the clinic with the promise of targeting cancer cells while steering clear of healthy tissue, according to the current edition of Chemical & Engineering News.
Nurses and other health professionals will soon be able to take a dedicated course on cancer rehabilitation at Swansea University. The master's module in cancer rehabilitation is being launched to help the training of health and social care staff.
Even though treatment for cholesterol disorders can reduce the risk of heart and blood vessel disease by about 30 percent over five years, many at-risk people aren't getting adequate treatment, according to researchers from Wake Forest University School of Medicine and colleagues reporting in Circulation: Journal of the American Heart Association.
Young people who have tried an e-cigarette may be more likely to go on to smoke cigarettes compared with those who have not, a study led by University of Stirling researchers has suggested.
› Verified 9 days ago
| Entity Name | Medical Center Radiologists Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720079254 PECOS PAC ID: 5395640650 Enrollment ID: O20031201000544 |
News Archive
Fate Therapeutics, Inc. announced today that the Company was named as one of Technology Review's 2010 TR50, the publication's first annual list of the 50 most innovative companies in the world. The 2010 TR50 companies span the fields of energy, computing, the Web, biomedicine, and materials and have been evaluated based on business model, strategies for deploying and scaling up its technologies and the likelihood of success. Each company in the 2010 TR50 has excelled not only at inventing technology but also at using it to transform how we live and work.
A new generation of cancer treatments based on nanotechnology is making its way out of the laboratory and into the clinic with the promise of targeting cancer cells while steering clear of healthy tissue, according to the current edition of Chemical & Engineering News.
Nurses and other health professionals will soon be able to take a dedicated course on cancer rehabilitation at Swansea University. The master's module in cancer rehabilitation is being launched to help the training of health and social care staff.
Even though treatment for cholesterol disorders can reduce the risk of heart and blood vessel disease by about 30 percent over five years, many at-risk people aren't getting adequate treatment, according to researchers from Wake Forest University School of Medicine and colleagues reporting in Circulation: Journal of the American Heart Association.
Young people who have tried an e-cigarette may be more likely to go on to smoke cigarettes compared with those who have not, a study led by University of Stirling researchers has suggested.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Adam Craig Lustig, MD Dept Of Radiology # 7510, 2107 Old Clinic Clb, Chapel Hill, NC 27599-0001 Ph: (804) 828-3524 | Adam Craig Lustig, MD 600 Gresham Dr, Norfolk, VA 23507-1904 Ph: (757) 466-0089 |
News Archive
Fate Therapeutics, Inc. announced today that the Company was named as one of Technology Review's 2010 TR50, the publication's first annual list of the 50 most innovative companies in the world. The 2010 TR50 companies span the fields of energy, computing, the Web, biomedicine, and materials and have been evaluated based on business model, strategies for deploying and scaling up its technologies and the likelihood of success. Each company in the 2010 TR50 has excelled not only at inventing technology but also at using it to transform how we live and work.
A new generation of cancer treatments based on nanotechnology is making its way out of the laboratory and into the clinic with the promise of targeting cancer cells while steering clear of healthy tissue, according to the current edition of Chemical & Engineering News.
Nurses and other health professionals will soon be able to take a dedicated course on cancer rehabilitation at Swansea University. The master's module in cancer rehabilitation is being launched to help the training of health and social care staff.
Even though treatment for cholesterol disorders can reduce the risk of heart and blood vessel disease by about 30 percent over five years, many at-risk people aren't getting adequate treatment, according to researchers from Wake Forest University School of Medicine and colleagues reporting in Circulation: Journal of the American Heart Association.
Young people who have tried an e-cigarette may be more likely to go on to smoke cigarettes compared with those who have not, a study led by University of Stirling researchers has suggested.
› Verified 9 days ago
Dr. Kevin Halista, M.D. Radiology Medicare: May Accept Medicare Assignments Practice Location: 110 Kingsley Ln, Suite 305, Norfolk, VA 23505 Phone: 804-262-6900 | |
Dr. Julie Anne Krumreich, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 218 E 42nd St, Norfolk, VA 23504 Phone: 757-963-6713 | |
Norbertina L Banson, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 835 Glenrock Rd, Ste 100a, Norfolk, VA 23502 Phone: 757-252-3370 Fax: 757-252-3225 | |
Mark Cockerill, MD Radiology Medicare: May Accept Medicare Assignments Practice Location: 150 Kingsley Ln, Norfolk, VA 23505 Phone: 757-889-5422 Fax: 757-889-5450 | |
Dr. Marc L Pessar, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 850 Kempsville Rd, Norfolk, VA 23502 Phone: 757-466-5910 Fax: 757-466-5748 | |
Dr. Suraj Jaisinghani, MD Radiology Medicare: Medicare Enrolled Practice Location: 600 Gresham Dr, Norfolk, VA 23507 Phone: 585-922-2932 | |
Todd Matthew Berry, MD Radiology Medicare: May Accept Medicare Assignments Practice Location: 110 Kingsley Ln Ste 305, Norfolk, VA 23505 Phone: 757-889-5422 Fax: 757-889-5450 |